FDA weighs J&J vaccine, House fo vote on COVID-19 relief bill, snow moon: 5 things you need to know Friday

FDA weighing approval of a third COVID-19 vaccine

A proposed new COVID-19 vaccine from Johnson & Johnson is expected to get a thumbs-up Friday from a Food and Drug Administration (FDA) advisory committee. If the FDA formally grants authorization as anticipated within the next few days the U.S. will have three approved vaccines. Like the other two, from Moderna and Pfizer-BioNTech, the Johnson & Johnson vaccine underwent a large clinical trial showing its safety and effectiveness. The J&J vaccine differs from the two already authorized, because only one shot is recommended, instead of two. Meanwhile, starting Friday, the COVID-19 vaccine will be available in select CVS stores in 17 states. The drugstore chain announced Wednesday that it would be expanding its vaccination rollout to pharmacies in six states: Alabama, Arizona, Florida, Louisiana, Ohio and Pennsylvania. 

Prefer to listen? Check out the 5 things podcast: 

Leave a Reply

Your email address will not be published.